BMC Infectious Diseases (Mar 2006)

Frequency of antimicrobial resistance among invasive and colonizing Group B Streptococcal isolates

  • Marrs Carl F,
  • Manning Shannon D,
  • Tallman Patricia A,
  • DeBusscher Joan H,
  • Borchardt Stephanie M,
  • Kurzynski Terrence A,
  • Foxman Betsy

DOI
https://doi.org/10.1186/1471-2334-6-57
Journal volume & issue
Vol. 6, no. 1
p. 57

Abstract

Read online

Background Group B Streptococcus (GBS) remains susceptible to penicillin, however, resistance to second-line antimicrobials, clindamycin and erythromycin, has increased since 1996. We describe the age-specific antibiotic susceptibility profile and capsular type distribution among invasive and colonizing GBS strains. Methods We tested 486 invasive GBS isolates from individuals of all ages collected by a Wisconsin surveillance system between 1998 and 2002 and 167 colonizing strains collected from nonpregnant college students during 2001 in Michigan. Antimicrobial susceptibility testing was performed by disk diffusion or Etest and capsular typing was performed using DNA dot blot hybridization Results 20.0% (97/486) of invasive and 40.7% (68/167) of colonizing isolates were resistant to clindamycin (P P P Conclusion Clindamycin and erythromycin resistance rates were high among isolates colonizing nonpregnant college students and invasive GBS isolates, particularly among the colonizing isolates. Susceptibility profiles were similar by age although the proportion of clindamycin and erythromycin resistance among invasive isolates was highest among persons 18–49 years of age. Increasing antimicrobial resistance has implications for GBS disease treatment and intrapartum prophylaxis among penicillin intolerant patients.